William Tansey
-
Promising drug-like compounds found to have strong action against blood cancers
For researchers, projects can sometimes feel like babies, and there is nothing more satisfying than seeing your baby grow up. For William Tansey, professor of cell and developmental biology, this baby started 10 years ago when he and Stephen Fesik, Orrin H. Ingram II, Professor of Cancer Research and professor… Read MoreSep. 3, 2024
-
New cancer target could push new drugs into the clinic
New work by Professor of Cell and Developmental Biology Bill Tansey and colleagues has determined that a new type of inhibitor—a WINi—targets cancer cells in a novel way and suggests exploiting this pathway in future anticancer drug development efforts. Read MoreMay. 14, 2024
-
DNA is the ultimate blueprint— but epigenetics changes how it’s read
William Tansey, professor of cell and developmental biology and biochemistry and co-leader of the Vanderbilt-Ingram Cancer Center Genome Maintenance Program, gives us a bird’s-eye view of epigenetics and some of Vanderbilt’s research contributions to the space. Read MoreMar. 7, 2024
-
Collaborative research lays groundwork for potential treatment of a rare and deadly type of cancer
A collaborative project between the labs of William Tansey, Ingram Professor of Cancer Research and professor of cell and developmental biology and biochemistry, and Stephen Fesik, Orrin H. Ingram II Chair in Cancer Research and professor of biochemistry, chemistry and pharmacology, has… Read MoreApr. 25, 2022
-
Attend ‘Survivor: Intersections of Cancer and Mental Health with Ethan Zohn’ on April 26
Ethan Zohn, winner of the CBS reality show Survivor, two-time cancer survivor, humanitarian and former professional soccer player, will discuss his journey with reality television, cancer, mental health and humanitarian work as part of the School of Medicine Basic Sciences’ monthly Lab-to-Table Conversations on Tuesday, April… Read MoreApr. 8, 2022